<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//explicyte.com/video-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-video/1.1 http://www.google.com/schemas/sitemap-video/1.1/sitemap-video.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:video="http://www.google.com/schemas/sitemap-video/1.1">
	<url>
		<loc>https://explicyte.com/explicyte-earns-iso-13485-and-iso-9001-certifications-for-clinical-tissue-biomarker-development-testing-in-oncology-trials/</loc>
		<video:video>
			<video:title><![CDATA[Explicyte earns ISO 13485 and ISO 9001 certifications for clinical tissue biomarker development &amp; testing in oncology trials | Explicyte]]></video:title>
			<video:description><![CDATA[Explicyte, a French precision oncology contract research organization (CRO), today announced that it has achieved ISO 13485:2016 and ISO 9001:2015 certifications for the design, development, and analysis of tissue-based clinical biomarkers to support precision oncology clinical trials. These certifications formalize Explicyte’s quality framework for delivering robust, reproducible, and traceable biomarker assays aligned with clinical-stage sponsor requirements.]]></video:description>
			<video:player_loc>https://www.youtube.com/embed/bmokMO6jCHc</video:player_loc>
			<video:thumbnail_loc>https://explicyte.com/wp-content/uploads/2026/06/Explicyte-ISO-certification-IHC-IHF-clinical-biomarkers.jpg</video:thumbnail_loc>
			<video:family_friendly>yes</video:family_friendly>
			<video:uploader info="https://explicyte.com/author/pegaultier/">Explicyte team</video:uploader>
		</video:video>
	</url>
	<url>
		<loc>https://explicyte.com/</loc>
		<video:video>
			<video:title><![CDATA[Precision Oncology &amp; Immuno-Oncology CRO | Explicyte]]></video:title>
			<video:description><![CDATA[Precision oncology &amp; immuno-oncology CRO supporting target discovery, preclinical studies, clinical biomarkers and multiomics analysis for biotech and pharma.]]></video:description>
			<video:player_loc>https://www.youtube.com/embed/324Nd-GKDX8</video:player_loc>
			<video:thumbnail_loc>https://explicyte.com/wp-content/uploads/2026/05/Explicyte-Precision-Oncology-and-Immuno-Oncology-CRO.jpg</video:thumbnail_loc>
			<video:family_friendly>yes</video:family_friendly>
			<video:uploader info="https://explicyte.com/author/pegaultier/">Explicyte team</video:uploader>
		</video:video>
	</url>
	<url>
		<loc>https://explicyte.com/oncology-cro-services/preclinical/</loc>
		<video:video>
			<video:title><![CDATA[Preclinical Immuno-Oncology CRO Services | Explicyte]]></video:title>
			<video:description><![CDATA[Profitez des vidéos et de la musique que vous aimez, mettez en ligne des contenus originaux, et partagez-les avec vos amis, vos proches et le monde entier.]]></video:description>
			<video:player_loc>https://www.youtube.com/embed/kPa3jReGspU</video:player_loc>
			<video:thumbnail_loc>https://explicyte.com/wp-content/uploads/2026/06/preclinical-immuno-oncology-CRO-services.jpg</video:thumbnail_loc>
			<video:family_friendly>yes</video:family_friendly>
			<video:uploader info="https://explicyte.com/author/pegaultier/">Explicyte team</video:uploader>
		</video:video>
	</url>
	<url>
		<loc>https://explicyte.com/oncology-cro-services/preclinical/cell-based-assays/immune-cell-migration/</loc>
		<video:video>
			<video:title><![CDATA[Cell Migration &amp; Chemotaxis Assays | Immune &amp; Tumor Cells]]></video:title>
			<video:description><![CDATA[Kinetic transwell migration and chemotaxis assays using primary immune cells and tumor-cell models to assess recruitment, trafficking and compound-driven migration.]]></video:description>
			<video:player_loc>https://www.youtube.com/embed/cfmxLc3TuVo</video:player_loc>
			<video:thumbnail_loc>https://explicyte.com/wp-content/uploads/2026/07/immune-cell-migration.jpg</video:thumbnail_loc>
			<video:family_friendly>yes</video:family_friendly>
			<video:uploader info="https://explicyte.com/author/pegaultier/">Explicyte team</video:uploader>
		</video:video>
	</url>
	<url>
		<loc>https://explicyte.com/oncology-cro-services/discovery/</loc>
		<video:video>
			<video:title><![CDATA[FFPE-Based Oncology Target Discovery | Explicyte]]></video:title>
			<video:description><![CDATA[Discover and prioritize oncology targets from clinically annotated FFPE cohorts, combining transcriptomic profiling, data science and tissue-based validation.]]></video:description>
			<video:player_loc>https://www.youtube.com/embed/cRL7FfbQPrY</video:player_loc>
			<video:thumbnail_loc>https://explicyte.com/wp-content/uploads/2026/06/Oncology-target-discovery-CRO-services-based-on-FFPE-tissues.jpg</video:thumbnail_loc>
			<video:family_friendly>yes</video:family_friendly>
			<video:uploader info="https://explicyte.com/author/pegaultier/">Explicyte team</video:uploader>
		</video:video>
	</url>
	<url>
		<loc>https://explicyte.com/oncology-cro-services/trials/iso-certified-pathology/</loc>
		<video:video>
			<video:title><![CDATA[IHC/IF Biomarker Assay Development &amp; Validation | Explicyte]]></video:title>
			<video:description><![CDATA[Develop and analytically validate IHC and multiplex IF tissue biomarker assays for oncology trials under Explicyte’s ISO 13485 and ISO 9001-certified QMS.]]></video:description>
			<video:player_loc>https://www.youtube.com/embed/bmokMO6jCHc</video:player_loc>
			<video:thumbnail_loc>https://explicyte.com/wp-content/uploads/2026/09/IHC-IF-Biomarker-Assay-Development-Validation-oncology-CRO-Explicyte.jpg</video:thumbnail_loc>
			<video:family_friendly>yes</video:family_friendly>
			<video:uploader info="https://explicyte.com/author/pegaultier/">Explicyte team</video:uploader>
		</video:video>
	</url>
	<url>
		<loc>https://explicyte.com/oncology-cro-services/discovery/ffpe-transcriptomics/</loc>
		<video:video>
			<video:title><![CDATA[Oncology Target Identification with FFPE Transcriptomics | Explicyte]]></video:title>
			<video:description><![CDATA[FFPE transcriptomics CRO for oncology target identification, combining single-cell, spatial and bulk profiling with in-house target ranking.]]></video:description>
			<video:player_loc>https://www.youtube.com/embed/zBbs6uRHXxg</video:player_loc>
			<video:thumbnail_loc>https://explicyte.com/wp-content/uploads/2026/06/Custom-fit-FFPE-transcriptomics-for-target-identification.jpg</video:thumbnail_loc>
			<video:family_friendly>yes</video:family_friendly>
			<video:uploader info="https://explicyte.com/author/pegaultier/">Explicyte team</video:uploader>
		</video:video>
	</url>
	<url>
		<loc>https://explicyte.com/about/careers-immuno-oncology-jobs-bordeaux-france/</loc>
		<video:video>
			<video:title><![CDATA[Careers | Immuno-Oncology Jobs in Bordeaux — Explicyte]]></video:title>
			<video:description><![CDATA[Explore careers at Explicyte, a specialty immuno-oncology CRO in Bordeaux. Join a human-sized team of scientists. Spontaneous applications welcome.]]></video:description>
			<video:player_loc>https://www.youtube.com/embed/2k4d6HJ927w</video:player_loc>
			<video:family_friendly>yes</video:family_friendly>
			<video:uploader info="https://explicyte.com/author/pegaultier/">Explicyte team</video:uploader>
		</video:video>
		<video:video>
			<video:title><![CDATA[Careers | Immuno-Oncology Jobs in Bordeaux — Explicyte]]></video:title>
			<video:description><![CDATA[Explore careers at Explicyte, a specialty immuno-oncology CRO in Bordeaux. Join a human-sized team of scientists. Spontaneous applications welcome.]]></video:description>
			<video:player_loc>https://www.youtube.com/embed/2mq7Gg2yf_E</video:player_loc>
			<video:family_friendly>yes</video:family_friendly>
			<video:uploader info="https://explicyte.com/author/pegaultier/">Explicyte team</video:uploader>
		</video:video>
		<video:video>
			<video:title><![CDATA[Careers | Immuno-Oncology Jobs in Bordeaux — Explicyte]]></video:title>
			<video:description><![CDATA[Explore careers at Explicyte, a specialty immuno-oncology CRO in Bordeaux. Join a human-sized team of scientists. Spontaneous applications welcome.]]></video:description>
			<video:player_loc>https://www.youtube.com/embed/t6YUVvhDKlU</video:player_loc>
			<video:family_friendly>yes</video:family_friendly>
			<video:uploader info="https://explicyte.com/author/pegaultier/">Explicyte team</video:uploader>
		</video:video>
		<video:video>
			<video:title><![CDATA[Careers | Immuno-Oncology Jobs in Bordeaux — Explicyte]]></video:title>
			<video:description><![CDATA[Explore careers at Explicyte, a specialty immuno-oncology CRO in Bordeaux. Join a human-sized team of scientists. Spontaneous applications welcome.]]></video:description>
			<video:player_loc>https://www.youtube.com/embed/hd-ic6J8URU</video:player_loc>
			<video:family_friendly>yes</video:family_friendly>
			<video:uploader info="https://explicyte.com/author/pegaultier/">Explicyte team</video:uploader>
		</video:video>
	</url>
	<url>
		<loc>https://explicyte.com/multiomics/bioinformatics/mif-ihc-image-analysis/</loc>
		<video:video>
			<video:title><![CDATA[mIF &amp; IHC Image Analysis for Digital Pathology | Explicyte]]></video:title>
			<video:description><![CDATA[Standalone mIF and IHC image analysis for FFPE digital pathology, including tissue and cell segmentation, ML-assisted phenotyping, spatial analysis and reporting.]]></video:description>
			<video:player_loc>https://www.youtube.com/embed/bmokMO6jCHc</video:player_loc>
			<video:thumbnail_loc>https://explicyte.com/wp-content/uploads/2026/07/mIF-IHC-Image-Analysis-FFPE-Digital-Pathology-Explicyte.jpg</video:thumbnail_loc>
			<video:family_friendly>yes</video:family_friendly>
			<video:uploader info="https://explicyte.com/author/pegaultier/">Explicyte team</video:uploader>
		</video:video>
	</url>
	<url>
		<loc>https://explicyte.com/multiomics/10x-genomics/</loc>
		<video:video>
			<video:title><![CDATA[10x Genomics Certified Service Provider | Explicyte]]></video:title>
			<video:description><![CDATA[Explicyte is a 10x Genomics Certified Service Provider for Xenium, Visium HD and Chromium X, with study design, sample preparation and in-house bioinformatics.]]></video:description>
			<video:player_loc>https://www.youtube.com/embed/zBbs6uRHXxg</video:player_loc>
			<video:thumbnail_loc>https://explicyte.com/wp-content/uploads/2026/08/Explicyte-10x-Genomics-Certified-Service-Provider-CRO-France-1.jpg</video:thumbnail_loc>
			<video:family_friendly>yes</video:family_friendly>
			<video:uploader info="https://explicyte.com/author/pegaultier/">Explicyte team</video:uploader>
		</video:video>
	</url>
	<url>
		<loc>https://explicyte.com/multiomics/spatial-biology-cro/digital-pathology/</loc>
		<video:video>
			<video:title><![CDATA[Digital Pathology CRO Services — IHC &amp; Multiplex IF | Explicyte]]></video:title>
			<video:description><![CDATA[Digital pathology CRO services from tissue processing and IHC/mIF staining to whole-slide imaging, pathologist scoring and quantitative biomarker analysis.]]></video:description>
			<video:player_loc>https://www.youtube.com/embed/bmokMO6jCHc</video:player_loc>
			<video:thumbnail_loc>https://explicyte.com/wp-content/uploads/2026/08/Digital-pathology-CRO-services.jpg</video:thumbnail_loc>
			<video:family_friendly>yes</video:family_friendly>
			<video:uploader info="https://explicyte.com/author/pegaultier/">Explicyte team</video:uploader>
		</video:video>
	</url>
	<url>
		<loc>https://explicyte.com/multiomics/</loc>
		<video:video>
			<video:title><![CDATA[Multiomics CRO Services | Transcriptomics &amp; Proteomics | Explicyte]]></video:title>
			<video:description><![CDATA[Multiomics CRO services combining single-cell and spatial transcriptomics, proteomics, flow cytometry and digital pathology with integrated in-house analysis.]]></video:description>
			<video:player_loc>https://www.youtube.com/embed/zBbs6uRHXxg</video:player_loc>
			<video:thumbnail_loc>https://explicyte.com/wp-content/uploads/2026/06/Transcriptomics-Multiomics-CRO-Services.jpg</video:thumbnail_loc>
			<video:family_friendly>yes</video:family_friendly>
			<video:uploader info="https://explicyte.com/author/pegaultier/">Explicyte team</video:uploader>
		</video:video>
	</url>
	<url>
		<loc>https://explicyte.com/a-second-xenium-explicyte-doubles-down-on-single-cell-spatial-transcriptomics/</loc>
		<video:video>
			<video:title><![CDATA[A second Xenium: Explicyte doubles down on single-cell spatial transcriptomics | Explicyte]]></video:title>
			<video:description><![CDATA[Bordeaux, France — December 3, 2025. A month after receiving the 10x Genomics’ « Certified Service Provider » designation across Xenium, Visium HD, and Chromium X, Explicyte, a French precision oncology contract research organization (CRO), today announced that it has doubled its capacity in single-cell spatial biology with the acquisition of a second Xenium platform.]]></video:description>
			<video:player_loc>https://www.youtube.com/embed/zBbs6uRHXxg</video:player_loc>
			<video:thumbnail_loc>https://explicyte.com/wp-content/uploads/2026/07/A-second-Xenium-Explicyte-doubles-down-on-single-cell-spatial-transcriptomics.jpg</video:thumbnail_loc>
			<video:family_friendly>yes</video:family_friendly>
			<video:uploader info="https://explicyte.com/author/pegaultier/">Explicyte team</video:uploader>
		</video:video>
	</url>
	<url>
		<loc>https://explicyte.com/single-cell-spatial-biology-explicyte-becomes-the-first-10x-genomics-certified-service-provider-in-france-for-xenium-studies/</loc>
		<video:video>
			<video:title><![CDATA[Single-Cell Spatial Biology: Explicyte Becomes the First 10x Genomics-Certified Service Provider in France for Xenium studies | Explicyte]]></video:title>
			<video:description><![CDATA[French CRO earns Xenium, Visium HD and Chromium X certification from 10x Genomics and deploys industrial-grade spatial biology platform to accelerate biomarker discovery &amp; drug development in oncology, and beyond.]]></video:description>
			<video:player_loc>https://www.youtube.com/embed/zBbs6uRHXxg</video:player_loc>
			<video:thumbnail_loc>https://explicyte.com/wp-content/uploads/2026/07/Explicyte-10x-Certified-Service-Provider-Xenium-CRO.jpg</video:thumbnail_loc>
			<video:family_friendly>yes</video:family_friendly>
			<video:uploader info="https://explicyte.com/author/pegaultier/">Explicyte team</video:uploader>
		</video:video>
	</url>
	<url>
		<loc>https://explicyte.com/ultra-trail-330-km-in-the-alpes-to-support-cancer-immunotherapy-research/</loc>
		<video:video>
			<video:title><![CDATA[Ultra-trail: 330 km in the Alpes to support cancer immunotherapy research | Explicyte]]></video:title>
			<video:description><![CDATA[From the 8th to the 14th of September, Gregory Lebras will run 330km in the Aosta Valley, in Italy. Enlisted for the TOR330 – TOR DES GÉANTS ultra-endurance trail together with 1,100 competitors, this anesthetist nurse at the Institut Bergonié Comprehensive Cancer Center aims to raise funds to support sarcoma research. Over 7 days, he will encourage his audience to make donations to the not-for-profit association “La Course du Petit Prince“.]]></video:description>
			<video:player_loc>https://www.youtube.com/embed/ejnRb2Acr3Y</video:player_loc>
			<video:thumbnail_loc>https://explicyte.com/wp-content/uploads/2024/06/Tor-geants-2024-explicyte-greg.jpg</video:thumbnail_loc>
			<video:family_friendly>yes</video:family_friendly>
			<video:uploader info="https://explicyte.com/author/pegaultier/">Explicyte team</video:uploader>
		</video:video>
	</url>
</urlset>
<!-- XML Sitemap generated by Rank Math SEO Plugin (c) Rank Math - rankmath.com -->